Metformin and lactic acidosis in patients with type 2 diabetes - from pride and prejudice to sense and sensibility

Acta Clinica Belgica

Volumn 64, Issue 1, 2009, Pages 42-48

  Papanas, N ^a,c   Monastiriotis, C ^a   Christakidis, D ^b   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c NONE   (Greece)

Author keywords

Biguanides; Diabetes mellitus; Lactic acidosis; Metformin

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; LACTIC ACID; METFORMIN; PIOGLITAZONE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; FEMALE; GASTROENTERITIS; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER CELL CARCINOMA; LIVER FAILURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; URINARY TRACT INFECTION;

EID: 61349161638     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2009.008     Document Type: Article

References (50)

1. Fantus IG. Metformin's contraindications: needed for now. CMA J 2005; 173: 505-7.
2. Misbin Rl. The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 2004; 27: 1791-3.
3. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-65.
4. Holstein A, Stumvoll M. Contraindications can damage your health-is metformin a case in point? Diabetologia 2005; 48: 2454-9.
5. McCormack J, Johns K,Tildesley H. Metformin's contraindications should be contraindicated. CMAJ 2005; 173: 502-4.
6. Emslie-Smith AM, Boyle Dl, Evans JM, Sullivan F, Morris AD. Contraindications to metformin therapy in patients with Type 2 diabetes-a population-based study of adherence to prescribing guidelines. Diabet Med 2001; 18: 483-8.
7. Holstein A, Egberts E-H. Traditional contraindications to the use of metformin-more harmful than beneficial? Dtsch Med Wschr 2006; 131: 105-10.
8. Stacpoole PW. Metformin and lactic acidosis: guilt by association (Editorial). Diabetes Care 1998; 21: 1587-8.
9. Stades AM, Heikens JT, Erkelens DW, Holleman F, Hoekstra JB. Metformin and lactic acidosis: cause or coincidence? A review of case reports J Intern Med 2004; 255: 179-87.
10. Stades AME, Heikens JT, Holleman F, Hoekstra JBL. Metformin-current restrictions should be alleviated. J Intern Med 2004; 256: 358.
11. Chang CT, Chen YC, Fang JT, Huang CC. Metformin-associated lactic acidosis: case reports and literature review.J Nephrol 2002; 15: 398-402.
12. Chu CK, Chang YT, Lee BJ, Hu SY, Hu WH, Yang DY. Metformin-associated lactic acidosis and acute renal failure in a type 2 diabetic patient, J Chin Med Assoc 2003; 66: 505-8.
13. Orban JC, Giunti C, Levraut J, Grimaud D, Ichai C. Metformin-associated lactic acidosis remains a serious complication of metformin therapy. Ann Fr Anesth Reanim 2003; 22: 461-5.
14. Moerer O, Barwing J, Neumann P. Lactic acidosis and acute abdomen from biguanide intoxication. Anaesthesist 2004; 53: 153-6.
15. Becker C, LuginbÜhl A, Pittl U, Schlienger R. Metformin-associated lactic acidosis in a patient with pre-existing risk factors. Schweiz Rundsch Med Prax 2005; 94: 1402-7.
16. Brassøe R, Elkmann T, Hempel M, Gravholt CH. Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin. Diabet Med 2005; 22: 1451-3.
17. DePalo VA, Mailer K. Yoburn D, Crausman RS. Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus. Geriatrics 2005; 60: 36-41.
18. Fox GN. Metformin in type 2 diabetes. J Fam Pract 2004; 53: 900.
19. Nyirenda MJ, Sandeep T, Grant I, Price G, McKnight JA. Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score. Diabet Med 2006; 23: 432-5.
20. Friesecke S, Abel P, Kraft M, Gerner A, Runge S. Combined renal replacement therapy for severe metformin-induced lactic acidosis. Nephrol Dial Transplant 2006; 21: 2038-9.
21. Shenoy C. Metformin-associated lactic acidosis precipitated by acute renal failure. Am J Med Sci 2006; 331: 55-7.
22. El-Hennawy AS, Jacob S, Mahmood AK. Metformin-associated lactic acidosis precipitated by diarrhea.Am J Ther 2007; 14: 403-5.
23. Ortega Carnicer J, Ambrós Checa A, Martin Rodríguez C, Ruiz Lorenzo F, Portilla Botelho M, Gómez Grande L. Metformin secondary to acute renal insufficiency: a report of six cases. Med Intensiva 2007; 31: 521-5.
24. Alivanis P, Giannikouris I, Paliuras C, Arvanitis A, Volanaki M, Zervos A. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther 2006; 28:396-400.
25. Berner B, Hummel KM, Strutz F, et al. Metformin-associated lactic acidosis with acute renal failure in type 2 diabetes mellitus. Med Klin (Munich) 2002; 97: 99-103.
26. PertekJP,VidalS,MariotJ, Galy-Floc'h M,AzoulayE. Metformin-associated lactic acidosis precipitated by acute renal failure. Ann FrAnasth Réanim 2003; 22: 457-60.
27. Chan NN, Brain HP, Feher MD. Metformin-associated lactic acidosis: a rare or very rare clinical entity? Diabet Med 1999; 16: 273-81.
28. Lalau J, Race J. Metformin and lactic acidosis in diabetic humans. Diabetes Obes Metab 2000; 2: 131-7.
29. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999; 22: 925-7.
30. Misbin Rl, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin. New Engl J Med 1998; 338: 265-6.
31. Salpeter SR, Greyber E, Pasternak G, Salpeter E. Risk of fatal and non-fatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; 1 CD002967.
32. Kamber N, Davis WA, Bruce DG, Davis TM. Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study. Med J Aust 2008; 188: 446-9.
33. Bailey CJ, Turner RC. Metformin. New Engl J Med 1996; 334: 574-9.
34. Bailey CJ, Howlett HC. Defining the risk of lactic acidosis. In: Bailey CJ, Campbell IW, Chan JC (Eds). Metformin: the gold standard. Chichester, UK: Wiley, 2007: 185-192.
35. Runge S, Mayerle J, Warnke C, et al. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation? Diabetes Obes Metabolism 2008; 10: 91-3.
36. Shaw JS, Wilmot RL, Kilpatrick ES. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing. Diabet Med 2007; 24: 1160-3.
37. Selby JV, Ettinger B, Swain BE, Brown JB. First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care 1999 22: 38-44.
38. Gregorio F, Ambrosi F, Filipponi P, Manfrini S, Testa I. Is metformin safe enough for ageing type 2 diabetic patients? Diabetes Metab 1996; 22: 43-50.
39. Holstein A, Nahrwold D, Hinze S, Egberts E-H. Contra-indications to metformin are largely disregarded. Diabet Med 1999; 16: 692-6.
40. Luft D, Deichsel G, Schmulling RM, Stein N, Eggstein M. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol 1983; 80: 484-9.
41. Davis TM, Jackson D, Davis WA, Bruce DG, Chubb P. The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: the Fremantle Diabetes Study. Br J Clin Pharmacol 2001; 52: 137-44.
42. Franzetti I, Paolo D, Marco G, Emanuela M, Elisabetta Z, Renato U. Possible synergistic effect of metformin and enalapril on the development of hyperkaliemic lactic acidosis. Diabetes Res Clin Pract 1997; 38: 173-6.
43. Chan NN, Fauvel NJ, Feher MD. Non-steroidal anti-inflammatory drugs and metformin: a cause for concern? Lancet 1998; 352: 201.
44. Lim VCC, Sum CF, Chan ESY, Yeoh LY, Lee YM, Lim SC. Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function. Int J Clin Pract 2007; 61: 1829-33.
45. Rakovac I, Jeitler K, Gfrerer RJ, et al. Patients with type 2 diabetes treated with metformin: prevalence of contraindications and their correlation with discontinuation. Diabet Med 2005; 22: 662-3.
46. Kennedy L, Herman WH. Renal status among patients using metformin in a primary care setting. Diabetes Care 2005; 28: 922-4.
47. Masoudi FA, Wang Y, Inzucchi SE, et al. Metformin and thiazoli-dinedione use in Medicare patients with heart failure. JAMA 2003; 290: 81-5.
48. Gras V, Bouffandeau B, Montravers PH, Lalau JD. Effect of metformin on survival rate in experimental sepsis. Diabetes Metab 2006; 32: 147-50.
49. Johnson JA, Simpson SH, Toth EL, Majumdar SR. Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes. Diabet Med 2005; 22: 497-502.
50. Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. CMAJ 2006; 174: 169-74.